EUVIMEDDescoperă EUVIMED
EUVIMED · CrossrefJournal

Leukemia

ISSN 0887-6924 · Springer Science and Business Media LLC

Latest articles

  1. Survival trends in Waldenström macroglobulinemia and comparison of outcomes with the general United States population

    Muhammad Azeem Khan, Gunjan Gaur, Jithma P. Abeykoon, Morie A. Gertz, Shaji Kumar, Rebecca L. King, Jonas Paludo, Thomas M. Habermann, Ronald S. Go, Joselle Cook, Nadine Abdallah, Gita Thanarajasingam, Francis Buadi, Angela Dispenzieri, Carrie A. Thompson, Wilson Gonsalves, Grzegorz S. Nowakowski, David Dingli, Eli Muchtar, Patricia T. Greipp, Surendra Dasari, Joseph Novak, Rahma Warsame, Thomas E. Witzig, S. Vincent Rajkumar, Stephen M. Ansell, Prashant Kapoor, Saurabh Zanwar

    Published: 2026-11-12DOI: 10.1038/s41375-026-03187-8

  2. Mutant calreticulin-driven myeloproliferative neoplasms favour the emergence of TIGIT-positive NK cells

    Agnieszka Witalisz-Siepracka, Theresa Harm, Thorsten Klampfl, Bernhard Zdársky, Brian Ringhofer, Elisabeth Gamper, Sophie Edtmayer, Uwe Graichen, Petra Pavić, Sabine Geiselhart, Johannes Foßelteder, Gregor Hoermann, Juan Li, Anthony R. Green, Carl Crodel, Joachim Wolff, Florian H. Heidel, Sascha Klee, Klaus Podar, Andreas Reinisch, Armin Zebisch, Karoline Kollmann, Dagmar Stoiber

    Published: 2026-11-03DOI: 10.1038/s41375-026-03175-y

  3. The cyclin-G associated kinase (GAK) is a clinically actionable drug target required for mitosis in diffuse large B-cell lymphoma

    Olivia B. Farag, Bassel Awada, Abdessamad A. Youssfi, Paola Manara, Anna Kingham, Preet Kumar, Lingxiao Li, Brian B. Silver, Toral Shastri, Santiago Vilar, Austin D. Newsam, Marianna Lekakis, Diego E. Hernandez Parets, Pierre A. Younes, Dhanvantri Chahar, Artavazd Arumov, Caroline A. Coughlin, Alicia Bilbao-Martinez, Mahesh Gokara, Francesco Maura, Stephan C. Schürer, Yangbo Feng, Vance Lemmon, Daniel Bilbao, Hassan Al-Ali, Jonathan H. Schatz

    Published: 2026-11-02DOI: 10.1038/s41375-026-03174-z

  4. Rapid proteasomal degradation of mutant feline McDonough sarcoma-like tyrosine kinase-3 overcomes inhibitor resistance mechanisms of acute myeloid leukemia cells

    Melisa Halilovic, Mohamed Abdelsalam, Andreas O. Mieland, Sarah Neuroth, Ramy Ashry, Marie E. S. Schwarting, Joanna Zabkiewicz, Michelle Lazenby, Caroline Alvares, Matthias Schmidt, Christian Marx, Andreas Schober, Sylvia Müller, Sebastian Drube, Monika Hartmann, Daniel Sasca, Walburgis Brenner, Sara Najafi, Ina Oehme, Christoph Hieber, Yanira Zeyn, Matthias Bros, Wolfgang Sippl, Oliver H. Krämer

    Published: 2026-10-28DOI: 10.1038/s41375-026-03168-x

  5. Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry

    Maël Heiblig, Zofia Gross, Amine Belhabri, Urbain Tauveron-Jalenques, Emmanuelle Tavernier, Gaspar Requena Aspas, Martin Carré, Adrien Contejean, Nadine Boullanger Fow Heng, Clémence Santana, Clément Rocher, Sylvain Lamure, Gian-Matteo Pica, Mauricette Michallet, Jérôme Cornillon, Mathieu Meunier, Natacha Mauz, Samy Chraibi, Ugo Thevenet, Arthur Dony, Grégoire Le Meur, Lucie Coster, Sylvie Tondeur, Emmanuel Beillard, Serge Carillo, Delphine Manzoni, Pascale Flandrin, Thomas Tassin, Sarah Huet, Adriana Plesa, Guieze Romain, Aspas Requena Gaspar, Fayard Amandine, Ravinet Aurélie, Abdo Chrystelle, Abitayeh Rami, Balsat Marie, Baroudi Nboureddine, Barraco Fiorenza, Beillard Emmanuel

    Published: 2026-10DOI: 10.1038/s41375-026-03024-y

  6. Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms

    Stephani Schmitz, Juliette E. Pearce, Sergio Martinez-Høyer, Gerjanne Vroeg in de wei, Inge A. M. Snoeren, Ursula S. A. Stalmann, Stijn N. R. Fuchs, Aurelien J. F. Dugourd, Giulia Franciosa, Eric M. Bindels, Wencke Walter, Claudia Meyer, Torsten Haferlach, Emiel P. C. van der Vorst, Oriol Calvete, Francesc Solé, Julio Saez-Rodriguez, Andreas Linkermann, Jesper Olsen, Hélène F. E. Gleitz, Rebekka K. Schneider

    Published: 2026-09-03DOI: 10.1038/s41375-026-03122-x

  7. Five-year follow-up of OPTIC: long-term efficacy, safety, and mutation analyses of ponatinib in chronic-phase chronic myeloid leukemia from a randomized phase 2 trial

    Hagop Kantarjian, Michael Deininger, Jane F. Apperley, Christopher Kevin Arthur, Charles Chuah, Andreas Hochhaus, Hugues de Lavallade, Jeffrey H. Lipton, Elza Lomaia, James McCloskey, Lori Maness, Michael Mauro, Beatriz Moiraghi, Carolina Pavlovsky, Gianantonio Rosti, Philippe Rousselot, Bo Chao, Alexander Vorog, L. Evan Reddick, Niti Patel, Meliessa Hennessy, Tammie Yeh, Jorge Cortes

    Published: 2026-09DOI: 10.1038/s41375-026-03009-x

  8. Plasticity under pressure: biology and detection of lineage switch in acute leukemia

    Alexandra E. Kovach, Yang-Yang Ding, Adam J. Lamble, Kathrin Bernt, Simon Bomken, Lisa E. Brodersen, Barbara Buldini, Dana Delgado Colon, Tim H. H. Coorens, Rula Green Gladden, Zhaohui Gu, Shimin Hu, Elad Jacoby, Derek Janssens, Jason H. Kurzer, Ester Mejstrikova, Sunil S. Raikar, Susan R. Rheingold, Sara K. Silbert, Kai Tan, Constance M. Yuan, Hao-Wei Wang, Sara Ghorashian, Nirali N. Shah, Kara L. Davis

    Published: 2026-09DOI: 10.1038/s41375-026-03020-2

  9. Choice of hypomethylating agent for newly diagnosed TP53-mutant acute myeloid Leukemia: a COMMAND registry study

    Talha Badar, James Foran, Omer Jamy, Chenyu Lin, Anand Patel, Yu-Hung Wang, Mahesh Kumar, Rory M. Shallis, Kendall Diebold, Alexander Coltoff, Aaron D. Goldberg, Jan P. Bewersdorf, Kenneth M. Zabel, Charles Foucar, Yasmin Abaza, Guru S. Murthy, Neil Palmisiano, Adam S. DuVall, Vamsi Kota, Shyam A. Patel, Amer M. Zeidan, Hemant Murthy, Mohamed Kharfan-Dabaja, Ehab Atallah, Mark R. Litzow

    Published: 2026-08-31DOI: 10.1038/s41375-026-03119-6

  10. Loss of systemic anti-viral immunity and LMP1-driven suppressive myeloid tumour niches converge to shape the immunobiology of Epstein-Barr virus-positive diffuse large B-cell lymphoma

    Éanna Fennell, Soi C. Law, Alexander C. Dowell, Matthew R. Pugh, Christina M. Enright, Aisling M. Ross, Aoife S. Hennessy, Ciara I. Leahy, Nadezhda Nikulina, Alex G. Richter, Lucia Mundo, Lorenzo Leoncini, Stefano Lazzi, Maria Chiara Siciliano, Stefan D. Dojcinov, Leticia Quintanilla-Martinez, Ken H. Young, Maher K. Gandhi, Graham S. Taylor, Paul G. Murray

    Published: 2026-08DOI: 10.1038/s41375-026-02994-3

  11. Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study

    S. Rinaldetti, M. Chepeleva, A. Hedblom, C. Sticht, M. Muciek, P. Panayiotidis, J. Richter, U. Olsson-Strömberg, D. Nowak, V. Nowak, P. Ljungman, N. von Bubnoff, K. Lotfi, L. Stenke, T. H. Brümmendorf, H. Hjorth-Hansen, T. Gedde-Dahl, W. Majeed, A. Burchert, P. V. Nazarov, E. Felde, I. Tarnopolscaia, C. Hoelting, A. Fabarius, W.-K. Hofmann, F.-X. Mahon, S. Saussele, M. Pfirrmann

    Published: 2026-08DOI: 10.1038/s41375-026-03001-5

  12. Immunophenotypic changes following menin inhibition in acute myeloid leukemia

    Sanam Loghavi, Aziz Farhat, Trevor J. Jamison, Georgina El Hajjar, Alex Bataller, Sa A. Wang, Wei Wang, Guilin Tang, Andres E. Quesada, Alexandre Bazinet, Branko Cuglievan, Courtney D. DiNardo, Guillermo Montalban-Bravo, Koichi Takahashi, Nicholas J. Short, Hussein A. Abbas, Tapan Kadia, Farhad Ravandi, Naval Daver, Elias Jabbour, Gautam Borthakur, Michael Andreeff, L. Jeffrey Medeiros, Hagop M. Kantarjian, Ghayas C. Issa

    Published: 2026-06DOI: 10.1038/s41375-026-02905-6

Volumes

2026 · 3232025 · 3602024 · 3562023 · 3232022 · 3582021 · 4322020 · 4032019 · 3182018 · 3402017 · 4142016 · 3782015 · 3362014 · 3852013 · 4042012 · 3772011 · 2832010 · 3352009 · 3682008 · 4132007 · 4762006 · 4402005 · 4552004 · 3632003 · 4152002 · 4012001 · 3732000 · 3591999 · 7141998 · 3271997 · 354

Cunoștințe potrivite muncii dumneavoastră.

De la începutul gratuit și cercetarea bibliografică personală până la Research Suite complet.

Vezi tarifele →

Sunt incluse toate textele integrale ale editorilor?

Nu. Referințele bibliografice, rezumatele și textele integrale sunt conținuturi diferite. Disponibilitatea unui text integral depinde de sursă, de Open Access și de licențele pe care le aveți deja. Un abonament EUVIMED nu înlocuiește drepturile suplimentare ale editorilor.